LENSAR (LNSR) Projected to Announce Quarterly Earnings on Tuesday

LENSAR (NASDAQ:LNSR) is expected to post its Q3 2026 results before the market opens on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.0950) per share and revenue of $14.30 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Tuesday, November 10, 2026 at 8:30 AM ET.

LENSAR (NASDAQ:LNSR) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.26. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%. The firm had revenue of $16.50 million during the quarter, compared to analysts’ expectations of $14.65 million.

LENSAR Price Performance

Shares of LNSR stock opened at $5.45 on Friday. LENSAR has a 1-year low of $4.95 and a 1-year high of $12.94. The stock’s fifty day moving average price is $6.78 and its 200 day moving average price is $7.36. The company has a market cap of $66.98 million, a price-to-earnings ratio of -16.52 and a beta of 1.03.

Wall Street Analyst Weigh In

LNSR has been the subject of a number of research analyst reports. BTIG Research increased their price target on LENSAR from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Wall Street Zen lowered LENSAR from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. Loop Capital set a $11.00 price objective on shares of LENSAR in a report on Monday, September 28th. Lake Street Capital restated a “buy” rating and set a $13.00 price objective on shares of LENSAR in a report on Thursday, August 13th. Finally, Weiss Ratings raised shares of LENSAR from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, October 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $11.33.

LENSAR Company Profile

LENSAR, Inc is a medical technology company focused on ophthalmic laser systems used in cataract surgery and other procedures involving the eye. The company develops and commercializes femtosecond laser technology designed to assist surgeons with key steps of cataract surgery, including corneal incisions, capsulotomy and lens fragmentation.

Its product portfolio includes the LENSAR Laser System, which incorporates image-guidance and planning technologies intended to support precise, customized procedures.